Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
5 Nasdaq Composite Laggards Likely to Gather Pace in 2024
09:47am, Tuesday, 19'th Dec 2023
We have narrowed our search to five Nasdaq Composite listed laggards of 2023 with strong potential for 2024. These are: PEP, KHC, WMG, PODD, BGNE.
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:17pm, Wednesday, 13'th Dec 2023
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Integra Gains From New Product Launches, Mounting Costs Ail
09:46am, Tuesday, 05'th Dec 2023
Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.
Top 5 Momentum Picks for December After Rejuvenated November
09:02am, Monday, 04'th Dec 2023
Five momentum stocks for December are: NVDA, VRT, CPRT, CEG, PODD.
4 Best Stocks to Invest in for Solid Earnings Growth
07:31am, Monday, 04'th Dec 2023
Invest in stocks such as Insulet (PODD), W.R. Berkley (WRB), Invitation Home (INVH) and VICI Properties (VICI) for superb earnings growth.
Insulet to Present at Upcoming Investor Conferences
06:00am, Tuesday, 28'th Nov 2023
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
02:17pm, Monday, 27'th Nov 2023
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Insulet (PODD) Up 31.5% Since Q3 Earnings: What's Driving It?
01:31pm, Thursday, 23'rd Nov 2023
Insulet (PODD) continues to gain from the strong adoption of Ommipod 5 and market expansion.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
10:31am, Thursday, 23'rd Nov 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
02:17pm, Friday, 10'th Nov 2023
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Wall Street sees these 2023 losers as 2024 opportunities
08:05am, Thursday, 09'th Nov 2023
The 2023 version of the U.S.
Surging Earnings Estimates Signal Upside for Insulet (PODD) Stock
01:31pm, Wednesday, 08'th Nov 2023
Insulet (PODD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Insulet (PODD) Banks on Omnipod for Consistent Market Share Gain
09:01am, Tuesday, 07'th Nov 2023
Insulet's (PODD) Omnipod 5 continues to be a driving force behind U.S. and international growth.
5 Stocks That Powered S&P 500 ETF Last Week
12:47pm, Monday, 06'th Nov 2023
After entering correction territory in the last week of October, the S&P 500 Index staged a solid comeback in the first week of November.
Wall Street Analysts Think Insulet (PODD) Could Surge 53.28%: Read This Before Placing a Bet
11:17am, Monday, 06'th Nov 2023
The consensus price target hints at a 53.3% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
